Innospec (IOSP)
(Delayed Data from NSDQ)
$121.65 USD
+1.65 (1.38%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $121.70 +0.05 (0.04%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth F Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$121.65 USD
+1.65 (1.38%)
Updated Nov 8, 2024 04:00 PM ET
After-Market: $121.70 +0.05 (0.04%) 7:58 PM ET
4-Sell of 5 4
C Value B Growth F Momentum B VGM
Zacks News
Innospec (IOSP) Q3 Earnings Meet Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Albemarle (ALB) Q3 Earnings Expected to Decline
by Zacks Equity Research
Albemarle (ALB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: Innospec (IOSP) Q3 Earnings Expected to Decline
by Zacks Equity Research
Innospec (IOSP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Tronox (TROX) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Tronox (TROX) delivered earnings and revenue surprises of -176.47% and 1.43%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Innospec's (IOSP) Q2 Earnings Surpass Estimates, Sales Miss
by Zacks Equity Research
Innospec (IOSP) sees strong results in its Performance Chemicals and Fuel Specialties segments in the second quarter on higher volumes.
Innospec (IOSP) Q2 Earnings Top Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 1.46% and 9.22%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Air Products and Chemicals (APD) Q3 Earnings Beat Estimates
by Zacks Equity Research
Air Products and Chemicals (APD) delivered earnings and revenue surprises of 5.26% and 1.79%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Albemarle (ALB) Misses Q2 Earnings Estimates
by Zacks Equity Research
Albemarle (ALB) delivered earnings and revenue surprises of -92.45% and 2.12%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
PPG Industries (PPG) Q2 Earnings Top Estimates, Sales Lag
by Zacks Equity Research
PPG Industries (PPG) second-quarter revenues are adversely impacted by unfavorable foreign currency translation.
Innospec (IOSP) Stock Jumps 3.8%: Will It Continue to Soar?
by Zacks Equity Research
Innospec (IOSP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Northern Technologies (NTIC) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Northern Technologies (NTIC) delivered earnings and revenue surprises of -54.17% and 10.06%, respectively, for the quarter ended May 2024. Do the numbers hold clues to what lies ahead for the stock?
Innospec (IOSP) Up 19% in a Year: What's Driving the Stock?
by Zacks Equity Research
Innospec's (IOSP) strong earnings performance, strength in the Performance Chemicals segment and strategic growth initiatives, including the QGP acquisition in Brazil, contribute to its shares' rally.
Innospec (IOSP) & IJM Collaborate to Protect Palm Oil Workers
by Zacks Equity Research
Innospec (IOSP) partners with IJM to combat forced labor in the Southeast Asia palm oil sector.
Innospec (IOSP) Shares Up 24% in Six Months: What's Driving It?
by Zacks Equity Research
Strength in the Performance Chemicals segment and strategic growth initiatives boost Innospec's (IOSP) earnings. This is supported by a key acquisition in Brazil and a robust, debt-free balance sheet.
Innospec's (IOSP) Q1 Earnings Surpass Estimates, Sales Lag
by Zacks Equity Research
Strong results in the Performance Chemicals segment drove Innospec's (IOSP) earnings in Q1.
Innospec Inc. (IOSP) Hits Fresh High: Is There Still Room to Run?
by Zacks Equity Research
Innospec (IOSP) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Innospec (IOSP) Q1 Earnings Beat Estimates
by Zacks Equity Research
Innospec (IOSP) delivered earnings and revenue surprises of 6.71% and 1.56%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Kronos Worldwide (KRO) Q1 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Kronos Worldwide (KRO) delivered earnings and revenue surprises of 75% and 5.31%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Kinross' (KGC) Earnings and Sales Surpass Estimates in Q1
by Zacks Equity Research
Kinross' (KGC) first-quarter earnings and sales beat estimates on higher gold production.
Quaker Chemical's (KWR) Q1 Earnings Beat Estimates, Sales Lag
by Zacks Equity Research
Lower selling prices and product mix as well as reduced volumes weigh on Quaker Chemical's (KWR) top line in Q1.
Centrus Energy (LEU) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Centrus Energy's (LEU) first-quarter 2024 results are likely to reflect the impact of higher uranium sales and prices as well as increased technical and other work under the HALEU Operation Contract.
Celanese (CE) to Report Q1 Earnings: What's in the Offing?
by Zacks Equity Research
Celanese (CE) is expected to have benefited from cost-cutting and efficiency initiatives, as well as investments in high-return organic projects and acquisition synergies in Q1.
Cabot (CBT) Surpasses Q2 Earnings Estimates
by Zacks Equity Research
Cabot (CBT) delivered earnings and revenue surprises of 7.23% and 3.33%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Denison Mine (DNN) to Report Q1 Earnings: What's in Store?
by Zacks Equity Research
Denison Mine's (DNN) first-quarter 2024 results are likely to reflect the impact of higher uranium sales and prices but are expected to be offset by seasonally higher exploration and evaluation costs.
Arcadium Lithium (ALTM) to Post Q1 Earnings: What's in Store?
by Zacks Equity Research
Arcadium Lithium (ALTM) is likely to have gained from higher overall volumes in the first quarter amid pricing headwinds.